Gozetotide (Locametz)

Status:
Do Not Prescribe (DNP)
Decision Date:
October 2022
 

Comments

DNP:

  • Treatment of partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa in patients aged ≥6 month
  • Identification of prostate-specific membrane antigen-positive lesions by positron emission tomography in adults with prostate cancer, after radiolabelling with gallium-68. Await clinician request or national guidance. (Decision date - November 2022)

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app